It is well known that in the field of tumour immunotherapy, five immune checkpoints, namely, PD-1, CTLA-4, Tim-3, LAG-3, and TIGIT, have inhibitory effects on T-cell proliferation. The gene discussed is HAVCR2; the disease is neoplasm.